Interventional Study Scientist Medical Director Locations – GSK HQ UK, New Oxford Street & USA - Upper Providence/ Waltham MA Reports to: Head of Interventional & Supported Studies Join GSKs Medical Affairs team and be part of
We are seeking a highly capable and motivated scientist to join our biologics team. The ideal candidate will bring significant expertise in biologics engineering, design, production and characterization and have a good understanding of biologics drug discovery.
Scientist Closing Date: 28th September 2026 (COB) Business Introduction At GSK, we have bold ambitions for patients, aiming to positively impact the health of 2.5 billion people by the end of the decade. Our R&D focuses on
For candidates seeking to be located at our Stevenage site, this role will temporarily be based at Stevenage. However, the Company plans to relocate its offices to Cambridge, UK. The location of this role will therefore
Principal Scientist Closing Date: 1st October 2026 (COB) Business Introduction At GSK, we have bold ambitions for patients, aiming to positively impact the health of 2.5 billion people by the end of the decade. Our R&D focuses
At Gilead, we’re creating a healthier world for all people. For more than 35 years, we’ve tackled diseases such as HIV, viral hepatitis, COVID-19 and cancer – working relentlessly to develop therapies that help improve lives
Overview In this role, you lead a team of scientists focused on developing novel biologic therapies for autoimmune disease. You’ll oversee in vitro and in vivo pharmacology studies to support lead and early discovery programs, delivering data
Onsite Required United Kingdom - Oxford Full time R At Gilead, were creating a healthier world for all people. For more than 35 years, weve tackled diseases such as HIV, viral hepatitis, COVID-19 and cancer -
Description For candidates seeking to be located at our Stevenage site, this role will temporarily be based at Stevenage. However, the Company plans to relocate its offices to Cambridge, UK. The location of this role will
Business Introduction At GSK, we have bold ambitions for patients, aiming to positively impact the health of 2.5 billion people by the end of the decade. Our R&D focuses on discovering and delivering vaccines and medicines,
Business Introduction At GSK, we have bold ambitions for patients, aiming to positively impact the health of 2.5 billion people by the end of the decade. Our R&D focuses on discovering and delivering vaccines and medicines,
For candidates seeking to be located at our Stevenage site, this role will temporarily be based at Stevenage. However, the Company plans to relocate its offices to Cambridge, UK. The location of this role will therefore
Choose Wisely, Apply Confidently To maximize your opportunities at securing an Industrial Placement with us this year, we strongly advise that you apply to no more than 3 adverts. (For clarity, multiple roles within a single
We create a place where people can grow, be their best, be safe, and feel welcome, valued and included. We offer a competitive salary, an annual bonus based on company performance, healthcare and wellbeing programmes, pension
Salary for this Role: From £49,080 , plus benefits, subject to skills and experience Job Title:Bioinformatician/Computational Biologist Reports to:Ilaria Malanchi Closing Date:18/Oct/2026 23.59 GMT Job Description: Bioinformatician/Computational Biologist Contract term: This is a full-time, fixed term
Barrington James Limited is seeking an Associate Principal Scientist to lead preclinical in vivo pharmacology programmes across kidney and metabolic disease, with potential inflammation exposure. You will provide scientific direction from study design to data interpretation, while collaborating
Make your mark for patientsWe are looking for a Research Scientist Macrophage Immunology who is collaborative, analytical, and innovative to join our Immunology Research team, based in our Slough, UK (Windlesham from 2027).About the roleYou will play
Safety Scientist – SERM (Safety Evaluation and Risk Management)Closing Date: 7th September 2026 (COB)Business IntroductionAt GSK, we have bold ambitions for patients, aiming to positively impact the health of 2.5 billion people by the end of the
At Sygnature Discovery, we create exceptional scientific outcomes. For our customers, who bring life‑changing medicines to patients; and for our people, who help make this possible. We’re 700+ scientists from over 50 countries, working as one across
About Vernalis Working within our fully equipped research laboratories in Cambridge, our established group of scientists are world leaders in multiple hit-ID technologies and structure-based drug discovery. Our scientists develop and apply lead generation and structure-based methods to